-
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts
Source: Buzz FX / 14 Mar 2025 02:56:16 America/New_York
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Shares of Kymera Therapeutics, Inc.
Read more...